C11ORF46 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.40869538256538E-11 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.03009999999448E-06 |
Normal-vs-Stage2 |
9.398000E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
4.037400E-03 |
Stage1-vs-Stage2 |
6.376600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
3.074000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.931200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.47550005547004E-09 |
Normal-vs-AfricanAmerican |
1.44329999995918E-06 |
Normal-vs-Asian |
6.64670000150025E-08 |
Caucasian-vs-AfricanAmerican |
7.792400E-01 |
Caucasian-vs-Asian |
1.301790E-01 |
AfricanAmerican-vs-Asian |
3.797000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.97059999995641E-06 |
Normal-vs-Female |
2.10629999997103E-07 |
Male-vs-Female |
2.348600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.379500E-04 |
Normal-vs-Extreme_Weight |
2.23699999999383E-05 |
Normal-vs-Obese |
2.838400E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.171800E-01 |
Normal_Weight-vs-Obese |
2.506400E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
5.698000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.252200E-02 |
Normal-vs-Age(41-60Yrs) |
3.172000E-04 |
Normal-vs-Age(61-80Yrs) |
2.85550000311829E-08 |
Normal-vs-Age(81-100Yrs) |
4.575000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.004040E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.815540E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.688600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.993800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.331400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.966800E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
3.622400E-01 |
Normal-vs-Grade 3 |
3.752800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
5.341600E-01 |
Grade 2-vs-Grade 4 |
3.622400E-01 |
Grade 3-vs-Grade 4 |
3.752800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.07229999826808E-08 |
Normal-vs-N1 |
2.664000E-03 |
N0-vs-N1 |
6.390100E-02 |
|
|